# OnCo record igm-biosciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/igm-biosciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "igm-biosciences" ;
  schema:name "IGM Biosciences"@en ;
  schema:description "IGM Biosciences engineered antibodies of the IgM class, which have ten binding arms instead of two, originally as T-cell engagers for blood cancers and later for autoimmune disease. It ended development and was bought by Concentra Biosciences in 2025."@en ;
  schema:url <https://onco.cc/companies/igm-biosciences/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.sec.gov/edgar/browse/?CIK=0001496323>, <https://www.sec.gov/Archives/edgar/data/1496323/000119312525153576/d82329dex991.htm>, <https://www.sec.gov/Archives/edgar/data/1496323/000119312525180763/d82965d8k.htm>, <https://www.sec.gov/edgar/browse/?CIK=0001496323> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/>, <https://onco.cc/technologies/t-cell-engager/> .